November 06, 2017
1 min read

At-home gluten test launched in US, Canada

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Glutenostics has launched an at-home gluten exposure test called Gluten Detective in the U.S. and Canada.

The test allows people on a gluten-free diet to test their urine or stool for gluten fragments consumed over the prior 1 to 2 or more days, according to a press release.

“This revolutionary and one-of-a-kind technology will empower people to take control of their gluten-free life and improve adherence to the diet through scientifically informed decision making,” David Winternheimer, PhD, CEO of Glutenostics, said in a press release. “Whatever your motive for maintaining gluten-free living, Gluten Detective is a flexible monitoring tool to provide valuable insight into your dietary composition, and afford users peace of mind.”

The technology was developed by a Spanish company called Biomedal, and Glutenostics is the exclusive licensee and distributor in the U.S. and Canada, where it will commercialize Gluten Detective as part of a global roll-out of lab- and home-based gluten tests.

Glutenostics also announced their new investor Patrick Baeuerle, “cited as the most successful biotech entrepreneur in Germany.”

“Glutenostics is transforming the way people live gluten-free, both with these novel tests and assessment of future product opportunities in our pipeline,” Winternheimer said in the press release.

Disclosures: Winternheimer is employed by Glutenostics.